메뉴 건너뛰기




Volumn 33, Issue 10, 2005, Pages 2241-2246

Recombinant activated factor VII for refractory bleeding after cardiac surgery - A retrospective analysis of safety and efficacy

Author keywords

Bleeding; Cardiac surgery; Hemostasis; Recombinant activated factor VII; Thromboembolism; Transfusion

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

EID: 26444442330     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000181527.47749.57     Document Type: Article
Times cited : (76)

References (23)
  • 1
    • 0029865807 scopus 로고    scopus 로고
    • Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations
    • Moulton MJ, Creswell LL, Mackey ME, et al: Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996; 111:1037-1046
    • (1996) J Thorac Cardiovasc Surg , vol.111 , pp. 1037-1046
    • Moulton, M.J.1    Creswell, L.L.2    Mackey, M.E.3
  • 2
    • 15644382459 scopus 로고    scopus 로고
    • Reexploration for hemorrhage following coronary artery bypass grafting
    • Dacey LJ, Munoz JJ, Baribeau YR, et al: Reexploration for hemorrhage following coronary artery bypass grafting. Arch Surg 1998; 133:442-447
    • (1998) Arch Surg , vol.133 , pp. 442-447
    • Dacey, L.J.1    Munoz, J.J.2    Baribeau, Y.R.3
  • 3
    • 0035163406 scopus 로고    scopus 로고
    • Mechanisms and attenuation of hemostatic activation during extracorporeal circulation
    • Despotis GJ, Avidan MS, Hogue CW Jr: Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001; 72:81821-81831
    • (2001) Ann Thorac Surg , vol.72 , pp. 81821-81831
    • Despotis, G.J.1    Avidan, M.S.2    Hogue Jr., C.W.3
  • 4
    • 0034045208 scopus 로고    scopus 로고
    • Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the treatment of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery
    • Al Douri M, Shafi T, Al Khudairi D: Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the treatment of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinol 2000; 11(Suppl 1):121-127
    • (2000) Blood Coagul Fibrinol , vol.11 , Issue.SUPPL. 1 , pp. 121-127
    • Al Douri, M.1    Shafi, T.2    Al Khudairi, D.3
  • 5
    • 0034914327 scopus 로고    scopus 로고
    • An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII
    • Hendriks HGD, van der Maaten JMAA, de Wolf J, et al: An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001; 93:287-289
    • (2001) Anesth Analg , vol.93 , pp. 287-289
    • Hendriks, H.G.D.1    Van Der Maaten, J.M.A.A.2    De Wolf, J.3
  • 6
    • 0036795428 scopus 로고    scopus 로고
    • Successful treatment of refractory bleeding with recombinant Factor VIIa after Redo coronary artery bypass grafting
    • von Heymann C, Hotz H, Konertz W, et al: Successful treatment of refractory bleeding with recombinant Factor VIIa after Redo coronary artery bypass grafting. J Cardiothorac Vasc Anesth 2002; 16:615-616
    • (2002) J Cardiothorac Vasc Anesth , vol.16 , pp. 615-616
    • Von Heymann, C.1    Hotz, H.2    Konertz, W.3
  • 7
    • 0036711777 scopus 로고    scopus 로고
    • Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta
    • Kastrup M, von Heymann C, Hotz H, et al: Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg 2002; 74:910-912
    • (2002) Ann Thorac Surg , vol.74 , pp. 910-912
    • Kastrup, M.1    Von Heymann, C.2    Hotz, H.3
  • 8
    • 0020678186 scopus 로고
    • Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs
    • Fritz H, Wunderer G: Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung 1983; 33:479-494
    • (1983) Arzneimittelforschung , vol.33 , pp. 479-494
    • Fritz, H.1    Wunderer, G.2
  • 9
    • 0033862187 scopus 로고    scopus 로고
    • The antithrombotic effect of aprotinin: Actions mediated via the protease activated receptor 1
    • Poullis M, Manning R, Laffan M, et al: The antithrombotic effect of aprotinin: Actions mediated via the protease activated receptor 1. J Thorac Cardiovasc Surg 2000; 120:370-378
    • (2000) J Thorac Cardiovasc Surg , vol.120 , pp. 370-378
    • Poullis, M.1    Manning, R.2    Laffan, M.3
  • 10
    • 0033542876 scopus 로고    scopus 로고
    • Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial
    • Despotis GJ, Levine V, Saleem R, et al: Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: A randomised controlled trial. Lancet 1999; 354:106-110
    • (1999) Lancet , vol.354 , pp. 106-110
    • Despotis, G.J.1    Levine, V.2    Saleem, R.3
  • 11
    • 0028133005 scopus 로고
    • Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery
    • Rocha E, Hidalgo F, Llorens R, et al: Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation 1994; 90:921-927
    • (1994) Circulation , vol.90 , pp. 921-927
    • Rocha, E.1    Hidalgo, F.2    Llorens, R.3
  • 12
    • 0037302940 scopus 로고    scopus 로고
    • Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: A prospective observational case series
    • Nuttall GA, Oliver WC Jr, Santrach PJ, et al: Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: A prospective observational case series. Anesth Analg 2003; 96:344-350
    • (2003) Anesth Analg , vol.96 , pp. 344-350
    • Nuttall, G.A.1    Oliver Jr., W.C.2    Santrach, P.J.3
  • 13
    • 0037389094 scopus 로고    scopus 로고
    • SCCM/ESICM: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
    • Levy MM, Fink MP, Marshall JC, et al: SCCM/ESICM: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
    • (2003) Crit Care Med , vol.31 , pp. 1250-1256
    • Levy, M.M.1    Fink, M.P.2    Marshall, J.C.3
  • 14
    • 0036217245 scopus 로고    scopus 로고
    • Cardiac operations for patients with chronic liver disease
    • Kaplan M, Cimen S, Kut MS, et al: Cardiac operations for patients with chronic liver disease. Heart Surg Forum 2002; 5:60-65
    • (2002) Heart Surg Forum , vol.5 , pp. 60-65
    • Kaplan, M.1    Cimen, S.2    Kut, M.S.3
  • 15
    • 0036109014 scopus 로고    scopus 로고
    • Aspirin and postoperative bleeding after coronary artery bypass grafting
    • Ferraris VA, Ferraris SP, Joseph O, et al: Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002; 235:820-827
    • (2002) Ann Surg , vol.235 , pp. 820-827
    • Ferraris, V.A.1    Ferraris, S.P.2    Joseph, O.3
  • 16
    • 0035671531 scopus 로고    scopus 로고
    • Effect of clopidogrel on bleeding after coronary artery bypass surgery
    • Yende S, Wunderink RG: Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29:2271-2275
    • (2001) Crit Care Med , vol.29 , pp. 2271-2275
    • Yende, S.1    Wunderink, R.G.2
  • 17
    • 0345352757 scopus 로고    scopus 로고
    • Multivariate predictors of blood product use in cardiac surgery
    • Parr KG, Patel MA, Dekker R, et al: Multivariate predictors of blood product use in cardiac surgery. J Cardiothorac Vasc Anesth 2003; 17:176-181
    • (2003) J Cardiothorac Vasc Anesth , vol.17 , pp. 176-181
    • Parr, K.G.1    Patel, M.A.2    Dekker, R.3
  • 18
    • 0037636659 scopus 로고    scopus 로고
    • Left ventricular assist devices and bleeding: Adding insult to injury
    • Goldstein DJ, Beauford RB: Left ventricular assist devices and bleeding: Adding insult to injury. Ann Thorac Surg 2003; 75(Suppl): S42-S47
    • (2003) Ann Thorac Surg , vol.75 , Issue.SUPPL.
    • Goldstein, D.J.1    Beauford, R.B.2
  • 19
    • 9244252471 scopus 로고    scopus 로고
    • Factors influencing haemostasis and blood transfusion in cardiac surgery
    • Liu B, Belboul A, Larsson S, et al: Factors influencing haemostasis and blood transfusion in cardiac surgery. Perfusion 1996; 11:131-143
    • (1996) Perfusion , vol.11 , pp. 131-143
    • Liu, B.1    Belboul, A.2    Larsson, S.3
  • 20
    • 0037452134 scopus 로고    scopus 로고
    • Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomized trial
    • Friederich PW, Henny CP, Messelink EJ, et al: Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomized trial. Lancet 2003; 361:201-205
    • (2003) Lancet , vol.361 , pp. 201-205
    • Friederich, P.W.1    Henny, C.P.2    Messelink, E.J.3
  • 21
    • 1842419461 scopus 로고    scopus 로고
    • "Last-ditch" use of recombinant factor VIIa in patients with massive haemorrhage is ineffective
    • Clark AD, Gordon WC, Walker ID, et al: "Last-ditch" use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang 2004; 86:120-124
    • (2004) Vox Sang , vol.86 , pp. 120-124
    • Clark, A.D.1    Gordon, W.C.2    Walker, I.D.3
  • 22
    • 0036898919 scopus 로고    scopus 로고
    • Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device
    • Potapov EV, Pasic M, Bauer M, et al: Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device. Ann Thorac Surg 2002; 74:2182-2183
    • (2002) Ann Thorac Surg , vol.74 , pp. 2182-2183
    • Potapov, E.V.1    Pasic, M.2    Bauer, M.3
  • 23
    • 12544249629 scopus 로고    scopus 로고
    • Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis
    • Karkouti K, Beattie WS, Wijeysundera DN, et al: Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis. Transfusion 2005; 45:26-34
    • (2005) Transfusion , vol.45 , pp. 26-34
    • Karkouti, K.1    Beattie, W.S.2    Wijeysundera, D.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.